首页|淋巴结比率对接受手术治疗的89例ⅢC1p期宫颈癌患者的预后价值

淋巴结比率对接受手术治疗的89例ⅢC1p期宫颈癌患者的预后价值

The prognostic value of lymph node ratio in 89 patients with stage ⅢC1p cervical cancer who underwent surgery

扫码查看
目的 探讨淋巴结比率(LNR)对2018年国际妇产科联盟(FIGO)ⅢC1p期宫颈癌患者的预后影响.方法 纳入2014年1月—2017年12月蚌埠医学院第一附属医院妇瘤科收治的89例淋巴结阳性宫颈癌患者,均接受了根治性子宫切除术以及系统性盆腔联合或不联合腹主动脉旁淋巴结切除术.所有患者术后均接受同步放化疗.LNR定义为阳性淋巴结与移除的淋巴结总数的比率.根据LNR将患者分为2组:LNR<0.06(42例)和LNR≥0.06(47例).LNR的预后价值通过log-rank检验和多变量Cox回归模型进行评估.结果 中位随访时间为44.6个月(范围为6~115个月),整个队列的5年无病生存(DFS)率为61.6%,5年总生存(OS)率为69.7%.LNR<0.06 和 LNR≥0.06 的 5 年 DFS 率分别为 65.4%和 54.2%(P=0.027).此外,LNR<0.06 和 LNR≥0.06 的5年OS率分别为82.8%和59.6%(P=0.003).在多变量分析中,LNR≥0.06与较差的DFS(HR=2.040,95%CI:1.130~3.870,P=0.013)和 OS(HR=1.940,95%CI:1.020~3.780,P=0.038)有相关性.结论 LNR≥0.06可能是ⅢC1p期宫颈癌患者DFS和OS下降的独立预后因素.
Objective To investigate the prognostic impact of lymph node ratio(LNR)on 2018 International Federation of Gynaecology and Obstetrics Stage ⅢC1p cervical cancer patients.Methods A total of 89 patients with lymph node-positive cervical cancer from January 2014 to December 2017 in the Oncology Department of the First Affiliated Hospital Bengbu Medical University underwent radical hysterectomy and systematic pelvic lymphadenectomy with or without ab-dominal aortic dissection.All patients received concurrent chemoradiotherapy.LNR was defined as the ratio of positive lymph nodes to the total number of LNS removed.Patients were divided into 2 groups according to LNR;LNR<0.06(42 cases)and LNR≥0.06(47 cases).The prognostic value of LNR was assessed by univariate log-rank test and multivari-able Cox regression models.Results The median follow-up was 44.6 months(range,6-115 months),and the 5-year disease-free survival(DFS)rate for the entire cohort was 61.6%,while the 5-year overall survival(OS)rate was 69.7%.The 5-year DFS rates for LNR<0.06 and LNR≥0.06 were 65.4%and 54.2%,respectively(P=0.027).Fur-thermore,the 5-year OS rates for LNR<0.06 and LNR≥0.06 were 82.8%and 59.6%,respectively(P=0.003).In multivariable analysis,LNR≥0.06 was associated with worse DFS(HR=2.040,95%CI:1.130-3.870,P=0.013)and OS(HR=1.940,95%CI:1.020-3.780,P=0.038).Conclusion LNR≥0.06 may be an independent prognos-tic factor for decreased DFS and OS in patients with stage ⅢC1P cervical cancer.

Cervical cancerLymph node ratioStage ⅢC1pPrognostic analysis

杨波、张庆松、王蓓蓓、倪芳芳、张颖、韩淑琪

展开 >

蚌埠医科大学第一附属医院肿瘤妇科,安徽蚌埠 233004

子宫颈癌 淋巴结比率 ⅢC1p期 预后分析

安徽省教育厅高等学校自然科学研究重点项目

2023AH051982

2024

中华全科医学
中华预防医学会,安徽省全科医学会

中华全科医学

CSTPCD
影响因子:1.688
ISSN:1674-4152
年,卷(期):2024.22(6)